Delivery Order SPE2DB22D3004-SPE2DB25FQM87
Award Date
5/1/25
Potential Completion Date
5/2/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Repatha, a specialty medication used to treat cardiovascular conditions, with a ceiling value of $1,845.45. It is a firm-fixed-price contract with an ultimate completion date of August 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Repatha (140 mg/mL SureClick). The contract has a firm fixed price of $1,041.42 and a period of performance through May 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha (140 mg/mL SureClick) medication. The contract has a ceiling value of $2,103.96 and a period of performance through February 18, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Repatha, a specialty medication used to treat cardiovascular conditions. The contract has a ceiling value of $4,174.14 and an ultimate completion date of August 2, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,742.10 firm fixed-price contract is for the supply of Repatha 140 mg/mL SureClick medication. The contract has a completion date of July 10, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $1,290.06 fixed-price contract is for the provision of the specialty drug Repatha (140 mg/mL) to support federal healthcare programs. This order falls under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as the primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Repatha 140 mg/mL SureClick injection medication. The contract has a firm fixed price of $1,098.00 and a period of performance through April 17, 2025. The contract is not set aside and allows for the delivery of a range of pharmaceutical products to support military and government healthcare programs. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,733.50, is for the supply of Repatha 140 mg/mL SureClick medication. It is a firm fixed-price contract with an ultimate completion date of April 22, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,041.42 contract is for the supply of Repatha, a 140 mg/mL injectable medication, with a period of performance through April 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, allowing the company to provide a wide range of pharmaceutical products and medical supplies to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $89,501.50, is for the supply of the specialty drug Repatha (140 mg/ml) to support military healthcare programs. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...